Shandong Xinhua Pharmaceutical Co Ltd banner

Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756

Watchlist Manager
Shandong Xinhua Pharmaceutical Co Ltd Logo
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Watchlist
Price: 15.31 CNY -0.39% Market Closed
Market Cap: ¥10.6B

Wall Street
Price Targets

Price Targets Summary
Shandong Xinhua Pharmaceutical Co Ltd

Wall Street analysts forecast Shandong Xinhua Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Xinhua Pharmaceutical Co Ltd is 11.73 CNY with a low forecast of 11.62 CNY and a high forecast of 12.08 CNY.

Lowest
Price Target
11.62 CNY
24% Downside
Average
Price Target
11.73 CNY
23% Downside
Highest
Price Target
12.08 CNY
21% Downside
Shandong Xinhua Pharmaceutical Co Ltd Competitors:
Price Targets
BTDR
Bitdeer Technologies Group
148% Upside
MZH
Nanofilm Technologies International Ltd
7% Upside
INMB
INmune Bio Inc
318% Upside
GFS
Globalfoundries Inc
20% Upside

Revenue
Forecast

8% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
8% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

10% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
10% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 3 years is 10%.

Net Income
Forecast

15% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
15% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Xinhua Pharmaceutical Co Ltd's stock price target?
Price Target
11.73 CNY

According to Wall Street analysts, the average 1-year price target for Shandong Xinhua Pharmaceutical Co Ltd is 11.73 CNY with a low forecast of 11.62 CNY and a high forecast of 12.08 CNY.

What is Shandong Xinhua Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 6%.

What is Shandong Xinhua Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 3 years is 10%.

What is Shandong Xinhua Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett